Bookmark

Add to MyYahoo RSS

Neoprobe News

News on Neoprobe (Ticker: NAVB) continually updated from thousands of sources around the net.

Friday Apr 11 | Sys-Con Media

Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market...

Its core product, Lymphoseek, a small-molecule radiopharmaceutical used in lymphatic mapping procedures, helps physician identify and target the lymph nodes that drain from a primary tumor that contain cancer cells.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Corporate / Securities Law, Law

Thu Apr 10, 2014

Benzinga

Navidea Announces Presentation of Study Findings of Manocept Platform ...

Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco presented results at the 2014 American Association for Cancer Research conference, April 5-9, 2014 in San Diego, CA, highlighting the potential ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, UC San Francisco

Wed Apr 09, 2014

Seeking Alpha

Navidea Continues To Execute, When Will The Stock Follow?

To be blunt, Navidea Biopharmaceuticals has been a poor performer over the past year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Wed Mar 19, 2014

Freshnews

Navidea Biopharmaceuticals Provides Update on European Marketing...

Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced that today it held an update meeting with the Committee for Medicinal Products for Human Use of the European Medicines Agency for the pending Marketing Authorization Application of Lymphoseek Injection.

Comment?

Related Topix: Biotech, Medicine, Marketing, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration

Fri Mar 14, 2014

Freshnews

Navidea Biopharmaceuticals Announces Presentation of LymphoseekA ...

Navidea Biopharmaceuticals, Inc. , a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced results of a three-year, voluntary follow-up study of Lymphoseek Injection conducted in patients who participated in a Phase 3 clinical trial of the product.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Health, Breast Cancer, Oncology, Food and Drug Administration

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••